The Outcome of Patients With Cystic Biliary Atresia With Intact Proximal Hepatic Ducts Following Hepatic-Cyst-Jejunostomy. Journal of Pediatric Gastroenterology and Nutrition. 2022; 75(2):131-137.
Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency. JHEP Reports. 2022; 4(4):100446.
Biliary Atresia and Other Disorders of the Extrahepatic Bile Ducts. In: Liver Disease in Children. Cambridge University Press (CUP); 2021:162-181.
Modeling Human Bile Acid Transport and Synthesis in Stem Cell-Derived Hepatocytes with a Patient-Specific Mutation. Stem Cell Reports. 2021; 16(2):309-323.
Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nature Reviews Gastroenterology and Hepatology. 2015; 12(6):342-352.
Baseline analysis of patient reported outcomes in the progressive familial intrahepatic cholestasis patient registry. Journal of Pediatric Gastroenterology and Nutrition. 2026.
68 Structural and Functional Development of the Hepatobiliary System. In: Pediatric Gastrointestinal and Liver Disease. Elsevier; 2026:809-817.e3.
Pharmacokinetic Monitoring of JAK Inhibitor and Tacrolimus for Safe and Effective Management of Graft-Versus-Host Disease After Pediatric Liver Transplantation. Pediatric Transplantation. 2025; 29(7):e70187.
Deriving Human Intestinal Organoids with Functional Tissue-Resident Macrophages All From Pluripotent Stem Cells. Cellular and Molecular Gastroenterology and Hepatology (CMGH). 2025; 19(4):101444.
Structural and Functional Development of the Hepatobiliary System. In: Pediatric Gastrointestinal and Liver Disease. 2025:809-817.e3.
Portal vein hypoplasia is present in patients with biliary atresia at the time of diagnosis. Journal of Pediatric Gastroenterology and Nutrition. 2024; 79(4):818-825.
Induced pluripotent stem cell (iPSC) modeling validates reduced GBE1 enzyme activity due to a novel variant, p.Ile694Asn, found in a patient with suspected glycogen storage disease IV. Molecular Genetics and Metabolism Reports. 2024; 39:101069.
Rapid in vivo evaluation system for cholestasis-related genes in mice with humanized bile acid profiles. Hepatology Communications. 2024; 8(4).
Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance. Hepatology Communications. 2023; 7(12).
Customized Postoperative Therapy Improves Bile Drainage in Biliary Atresia: A Single Center Preliminary Report. Journal of Pediatric Surgery. 2023; 58(8):1483-1488.
Recent Increase in Incidence of Severe Acute Hepatitis of Unknown Etiology in Children is Associated with Infection with Adenovirus and Other Nonhepatotropic Viruses. Journal of Pediatrics. 2023; 259:113439.
Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource. Molecular Genetics and Metabolism. 2023; 138(3):107525.
O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV* Genetics in Medicine Open. 2023; 1(1):100114.
Editorial: Infants with cholestasis. Frontiers in Pediatrics. 2023; 11:1175231.
Gas Leak in the Port: Portal Venous Gas Associated With Congenital Cytomegalovirus Colitis. JPGN Rep. 2022; 3(4):e267.
The Outcome of Patients With Cystic Biliary Atresia With Intact Proximal Hepatic Ducts Following Hepatic-Cyst-Jejunostomy. Journal of Pediatric Gastroenterology and Nutrition. 2022; 75(2):131-137.
In vivo partial cellular reprogramming enhances liver plasticity and regeneration. Cell reports. 2022; 39(4):110730.
Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency. JHEP Reports. 2022; 4(4):100446.